Clinical Trial Update: Evaluation of the Cost and Effectiveness Sunitinib Compared to Interferon-Alfa in Finland

View source ↗

Summary

This completed clinical trial compared the cost and effectiveness of sunitinib versus interferon-alpha in treating renal cell carcinoma in Finland.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Interferon Alfa (interferon alfa)
• Sunitinib (sunitinib)

Snippet

Sponsor: Pirkko-Liisa Kellokumpu-Lehtinen | Conditions: Neoplasms, Renal Cell Carcinoma | Status: COMPLETED